Article info
Rheumatoid arthritis
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset
- Correspondence to Professor Saedis Saevarsdottir, deCODE Genetics/Amgen, Reykjavik, Iceland; saedis.saevarsdottir{at}decode.is; Professor Kari Stefansson, deCODE genetics/Amgen, Reykjavik, Iceland; kstefans{at}decode.is
Citation
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset
Publication history
- Received October 26, 2021
- Accepted April 4, 2022
- First published April 25, 2022.
Online issue publication
July 12, 2022
Article Versions
- Previous version (25 April 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.